Literature DB >> 2010380

Effect of mild-to-moderate airflow limitation on exercise capacity.

T G Babb1, R Viggiano, B Hurley, B Staats, J R Rodarte.   

Abstract

To determine the effect of mild-to-moderate airflow limitation on exercise tolerance and end-expiratory lung volume (EELV), we studied 9 control subjects with normal pulmonary function [forced expired volume in 1 s (FEV1) 105% pred; % of forced vital capacity expired in 1 s (FEV1/FVC%) 81] and 12 patients with mild-to-moderate airflow limitation (FEV1 72% pred; FEV1/FVC % 58) during progressive cycle ergometry. Maximal exercise capacity was reduced in patients [69% of pred maximal O2 uptake (VO2max)] compared with controls (104% pred VO2max, P less than 0.01); however, maximal expired minute ventilation-to-maximum voluntary ventilation ratio and maximal heart rate were not significantly different between controls and patients. Overall, there was a close relationship between VO2max and FEV1 (r2 = 0.62). Resting EELV was similar between controls and patients [53% of total lung capacity (TLC)], but at maximal exercise the controls decreased EELV to 45% of TLC (P less than 0.01), whereas the patients increased EELV to 58% of TLC (P less than 0.05). Overall, EELV was significantly correlated to both VO2max (r = -0.71, P less than 0.001) and FEV1 (r = -0.68, P less than 0.001). This relationship suggests a ventilatory influence on exercise capacity; however, the increased EELV and associated pleural pressures could influence cardiovascular function during exercise. We suggest that the increase in EELV should be considered a response reflective of the effect of airflow limitation on the ventilatory response to exercise.

Entities:  

Mesh:

Year:  1991        PMID: 2010380     DOI: 10.1152/jappl.1991.70.1.223

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  21 in total

1.  Increases in .VO2max with "live high-train low" altitude training: role of ventilatory acclimatization.

Authors:  Daniel P Wilhite; Timothy D Mickleborough; Abigail S Laymon; Robert F Chapman
Journal:  Eur J Appl Physiol       Date:  2012-07-07       Impact factor: 3.078

2.  Continuous and intermittent exercise responses in individuals with chronic obstructive pulmonary disease.

Authors:  S Sabapathy; R A Kingsley; D A Schneider; L Adams; N R Morris
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

Review 3.  Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

4.  Operating lung volumes are affected by exercise mode but not trunk and hip angle during maximal exercise.

Authors:  Joseph W Duke; Jonathon L Stickford; Joshua C Weavil; Robert F Chapman; Joel M Stager; Timothy D Mickleborough
Journal:  Eur J Appl Physiol       Date:  2014-08-02       Impact factor: 3.078

Review 5.  Exercise ventilatory limitation: the role of expiratory flow limitation.

Authors:  Tony G Babb
Journal:  Exerc Sport Sci Rev       Date:  2013-01       Impact factor: 6.230

Review 6.  Exercise in patients with chronic obstructive pulmonary disease.

Authors:  M J Belman
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

7.  Respiratory mechanics during exercise in endurance-trained men and women.

Authors:  Jordan A Guenette; Jonathan D Witt; Donald C McKenzie; Jeremy D Road; A William Sheel
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

Review 8.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

9.  Inspiratory Capacity during Exercise: Measurement, Analysis, and Interpretation.

Authors:  Jordan A Guenette; Roberto C Chin; Julia M Cory; Katherine A Webb; Denis E O'Donnell
Journal:  Pulm Med       Date:  2013-02-07

10.  Mechanisms of physical activity limitation in chronic lung diseases.

Authors:  Ioannis Vogiatzis; George Zakynthinos; Vasileios Andrianopoulos
Journal:  Pulm Med       Date:  2012-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.